Official title and information are available only for Plus and Premium subscribers.
Patent Granted Antibodies against proliferating cell nuclear antigen (PCNA) or monoclonal antibody termed Ki-67 can be used for grading of different neoplasms, e.g. astrocytoma. They can be of diagnostic and prognostic value. However, an important limitation of antibodies is that cells need to be fixed leading to potential artifacts.
To see the additional information details please login and subscribe to a Plus or Premium account.
